Titre : Pulvérisations nasales

Pulvérisations nasales : Questions médicales fréquentes

{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Pulvérisations nasales : Questions médicales les plus fréquentes", "headline": "Pulvérisations nasales : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Pulvérisations nasales : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-06-16", "dateModified": "2025-12-08", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Pulvérisations nasales" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Aérosols", "url": "https://questionsmedicales.fr/mesh/D000336", "about": { "@type": "MedicalCondition", "name": "Aérosols", "code": { "@type": "MedicalCode", "code": "D000336", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D26.255.165.055" } } }, "about": { "@type": "MedicalCondition", "name": "Pulvérisations nasales", "alternateName": "Nasal Sprays", "code": { "@type": "MedicalCode", "code": "D059085", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Laleh Golshahi", "url": "https://questionsmedicales.fr/author/Laleh%20Golshahi", "affiliation": { "@type": "Organization", "name": "Department of Mechanical and Nuclear Engineering, Virginia Commonwealth University, Richmond, VA, USA. Electronic address: lgolshahi@vcu.edu." } }, { "@type": "Person", "name": "Kiao Inthavong", "url": "https://questionsmedicales.fr/author/Kiao%20Inthavong", "affiliation": { "@type": "Organization", "name": "School of Engineering (Mechanical & Automotive), RMIT University, Bundoora, Victoria, Australia." } }, { "@type": "Person", "name": "Ross Walenga", "url": "https://questionsmedicales.fr/author/Ross%20Walenga", "affiliation": { "@type": "Organization", "name": "Division of Quantitative Methods and Modeling, Office of Research and Standards, Office of Generic Drugs, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, USA." } }, { "@type": "Person", "name": "Worth Longest", "url": "https://questionsmedicales.fr/author/Worth%20Longest", "affiliation": { "@type": "Organization", "name": "Department of Mechanical and Nuclear Engineering, Virginia Commonwealth University, Richmond, VA, USA; Department of Pharmaceutics, Virginia Commonwealth University, Richmond, VA, USA." } }, { "@type": "Person", "name": "Michael Hindle", "url": "https://questionsmedicales.fr/author/Michael%20Hindle", "affiliation": { "@type": "Organization", "name": "Department of Pharmaceutics, Virginia Commonwealth University, Richmond, VA, USA." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "The Efficacy and Safety of Etripamil Nasal Spray for Acute Paroxysmal Supraventricular Tachycardia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.", "datePublished": "2023-06-23", "url": "https://questionsmedicales.fr/article/37351813", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s40256-023-00592-7" } }, { "@type": "ScholarlyArticle", "name": "Predictors of response and remission in patients with treatment-resistant depression: A post hoc pooled analysis of two acute trials of esketamine nasal spray.", "datePublished": "2023-03-16", "url": "https://questionsmedicales.fr/article/37019044", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.psychres.2023.115165" } }, { "@type": "ScholarlyArticle", "name": "Long-term safety and maintenance of response with esketamine nasal spray in participants with treatment-resistant depression: interim results of the SUSTAIN-3 study.", "datePublished": "2023-05-12", "url": "https://questionsmedicales.fr/article/37173512", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1038/s41386-023-01577-5" } }, { "@type": "ScholarlyArticle", "name": "Access and real-world use patterns of esketamine nasal spray among patients with treatment-resistant depression covered by private or public insurance.", "datePublished": "2023-08-03", "url": "https://questionsmedicales.fr/article/37492015", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1080/03007995.2023.2239045" } }, { "@type": "ScholarlyArticle", "name": "Safety of Diazepam Nasal Spray in Pediatric Patients With Developmental Epileptic Encephalopathies: Results From a Long-term Phase 3 Safety Study.", "datePublished": "2023-07-16", "url": "https://questionsmedicales.fr/article/37455404", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1177/08830738231185424" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Préparations pharmaceutiques", "item": "https://questionsmedicales.fr/mesh/D004364" }, { "@type": "ListItem", "position": 3, "name": "Colloïdes", "item": "https://questionsmedicales.fr/mesh/D003102" }, { "@type": "ListItem", "position": 4, "name": "Aérosols", "item": "https://questionsmedicales.fr/mesh/D000336" }, { "@type": "ListItem", "position": 5, "name": "Pulvérisations nasales", "item": "https://questionsmedicales.fr/mesh/D059085" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Pulvérisations nasales - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Pulvérisations nasales", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2026-02-06", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Pulvérisations nasales", "description": "Comment diagnostiquer une rhinite allergique ?\nQuels symptômes indiquent une sinusite ?\nQuels tests pour évaluer une infection nasale ?\nComment différencier rhume et allergies ?\nQuels signes d'une polypose nasale ?", "url": "https://questionsmedicales.fr/mesh/D059085?page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Pulvérisations nasales", "description": "Quels sont les symptômes d'une sinusite aiguë ?\nComment se manifeste une rhinite allergique ?\nQuels symptômes d'une infection virale ?\nQuels signes d'une irritation nasale ?\nQuels symptômes d'une sinusite chronique ?", "url": "https://questionsmedicales.fr/mesh/D059085?page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Pulvérisations nasales", "description": "Comment prévenir les allergies saisonnières ?\nQuelles mesures pour éviter la sinusite ?\nComment réduire l'irritation nasale ?\nQuelles précautions en hiver pour le nez ?\nComment éviter les infections nasales ?", "url": "https://questionsmedicales.fr/mesh/D059085?page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Pulvérisations nasales", "description": "Comment fonctionnent les pulvérisations nasales ?\nQuels types de pulvérisations nasales existent ?\nQuand utiliser un corticostéroïde nasal ?\nQuels sont les effets secondaires des pulvérisations ?\nComment utiliser correctement une pulvérisation nasale ?", "url": "https://questionsmedicales.fr/mesh/D059085?page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Pulvérisations nasales", "description": "Quelles complications d'une sinusite non traitée ?\nQuels risques d'une utilisation excessive de sprays ?\nQuelles complications d'une rhinite allergique ?\nQuels effets d'une sinusite chronique ?\nQuelles complications d'une infection virale ?", "url": "https://questionsmedicales.fr/mesh/D059085?page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Pulvérisations nasales", "description": "Quels facteurs augmentent le risque de sinusite ?\nQui est à risque de rhinite allergique ?\nQuels comportements augmentent l'irritation nasale ?\nQuels sont les risques liés à l'âge ?\nComment le climat influence-t-il les allergies ?", "url": "https://questionsmedicales.fr/mesh/D059085?page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une rhinite allergique ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Un examen clinique et des tests cutanés ou sanguins pour les allergènes sont nécessaires." } }, { "@type": "Question", "name": "Quels symptômes indiquent une sinusite ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Douleurs faciales, congestion nasale, écoulement nasal purulent et fièvre peuvent indiquer une sinusite." } }, { "@type": "Question", "name": "Quels tests pour évaluer une infection nasale ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Un examen physique et éventuellement une imagerie comme un scanner des sinus peuvent être réalisés." } }, { "@type": "Question", "name": "Comment différencier rhume et allergies ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Le rhume présente des symptômes de fièvre et de fatigue, tandis que les allergies causent des démangeaisons." } }, { "@type": "Question", "name": "Quels signes d'une polypose nasale ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Congestion persistante, perte de l'odorat et écoulement nasal chronique peuvent indiquer des polypes." } }, { "@type": "Question", "name": "Quels sont les symptômes d'une sinusite aiguë ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Douleur faciale, congestion, écoulement nasal purulent et parfois fièvre sont fréquents." } }, { "@type": "Question", "name": "Comment se manifeste une rhinite allergique ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Éternuements, démangeaisons, écoulement nasal clair et congestion sont des symptômes typiques." } }, { "@type": "Question", "name": "Quels symptômes d'une infection virale ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Écoulement nasal, toux, maux de gorge et fatigue sont souvent présents lors d'infections virales." } }, { "@type": "Question", "name": "Quels signes d'une irritation nasale ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Sécheresse, démangeaisons et saignements peuvent indiquer une irritation des muqueuses nasales." } }, { "@type": "Question", "name": "Quels symptômes d'une sinusite chronique ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Congestion persistante, écoulement nasal, fatigue et douleurs faciales sont des signes fréquents." } }, { "@type": "Question", "name": "Comment prévenir les allergies saisonnières ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Évitez les allergènes, utilisez des filtres à air et prenez des antihistaminiques préventifs." } }, { "@type": "Question", "name": "Quelles mesures pour éviter la sinusite ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Hydratez-vous, évitez le tabac et traitez rapidement les infections respiratoires." } }, { "@type": "Question", "name": "Comment réduire l'irritation nasale ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Utilisez un humidificateur, évitez les irritants et hydratez les muqueuses nasales." } }, { "@type": "Question", "name": "Quelles précautions en hiver pour le nez ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Protégez-vous du froid, hydratez-vous et évitez les changements brusques de température." } }, { "@type": "Question", "name": "Comment éviter les infections nasales ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Lavez-vous les mains régulièrement et évitez le contact avec des personnes malades." } }, { "@type": "Question", "name": "Comment fonctionnent les pulvérisations nasales ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Elles délivrent des médicaments directement dans les voies nasales pour un effet local rapide." } }, { "@type": "Question", "name": "Quels types de pulvérisations nasales existent ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "On trouve des décongestionnants, des antihistaminiques et des corticostéroïdes en pulvérisation." } }, { "@type": "Question", "name": "Quand utiliser un corticostéroïde nasal ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Pour traiter les inflammations chroniques comme la rhinite allergique ou la sinusite." } }, { "@type": "Question", "name": "Quels sont les effets secondaires des pulvérisations ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Irritation nasale, saignements et, dans certains cas, dépendance aux décongestionnants." } }, { "@type": "Question", "name": "Comment utiliser correctement une pulvérisation nasale ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Inclinez légèrement la tête en avant, insérez l'embout et pulvérisez tout en inspirant doucement." } }, { "@type": "Question", "name": "Quelles complications d'une sinusite non traitée ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Peut entraîner des infections oculaires, des abcès cérébraux ou des infections de l'oreille." } }, { "@type": "Question", "name": "Quels risques d'une utilisation excessive de sprays ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Peut provoquer une rhinite médicamenteuse, entraînant une congestion chronique." } }, { "@type": "Question", "name": "Quelles complications d'une rhinite allergique ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Peut aggraver l'asthme et entraîner des infections des sinus ou de l'oreille." } }, { "@type": "Question", "name": "Quels effets d'une sinusite chronique ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Peut causer des douleurs faciales persistantes et affecter la qualité de vie." } }, { "@type": "Question", "name": "Quelles complications d'une infection virale ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Peut évoluer vers des infections bactériennes secondaires, comme une sinusite ou une otite." } }, { "@type": "Question", "name": "Quels facteurs augmentent le risque de sinusite ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Allergies, infections respiratoires fréquentes et anomalies anatomiques des sinus augmentent le risque." } }, { "@type": "Question", "name": "Qui est à risque de rhinite allergique ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Les personnes ayant des antécédents familiaux d'allergies ou exposées à des allergènes sont à risque." } }, { "@type": "Question", "name": "Quels comportements augmentent l'irritation nasale ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Fumer, vivre dans des environnements secs ou pollués et utiliser des sprays excessivement." } }, { "@type": "Question", "name": "Quels sont les risques liés à l'âge ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Les enfants et les personnes âgées sont plus susceptibles de développer des infections nasales." } }, { "@type": "Question", "name": "Comment le climat influence-t-il les allergies ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Les saisons et l'humidité peuvent exacerber les symptômes allergiques chez certaines personnes." } } ] } ] }

Sources (3616 au total)

The Efficacy and Safety of Etripamil Nasal Spray for Acute Paroxysmal Supraventricular Tachycardia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Paroxysmal supraventricular tachycardia (PSVT) treatment requires medically supervised intervention. Etripamil is a novel short-acting calcium channel blocker. Its intranasal spray formulation has a r... We aimed to evaluate the efficacy and safety of etripamil nasal spray for the acute conversion of PSVT.... A systematic review and meta-analysis synthesizing randomized controlled trials (RCTs), which were retrieved by systematically searching the PubMed, EMBASE, Web of Science, SCOPUS, and Cochrane databa... Three RCTs with a total of 496 participants were included in our analysis. Etripamil was effective for PSVT conversion at 15 min (RR 1.84, 95% CI 1.37-2.48), 30 min (RR 1.86, 95% CI 1.42-2.44), and 60... Etripamil nasal spray was effective and well tolerated to induce PSVT termination for up to 60 min. Therefore, etripamil nasal spray constitutes a promising strategy for PSVT self-termination without ...

Predictors of response and remission in patients with treatment-resistant depression: A post hoc pooled analysis of two acute trials of esketamine nasal spray.

This exploratory post hoc analysis of two pooled 4-week, phase 3, double-blind, placebo- and active-controlled studies that compared esketamine nasal spray plus a newly initiated oral antidepressant (...

Long-term safety and maintenance of response with esketamine nasal spray in participants with treatment-resistant depression: interim results of the SUSTAIN-3 study.

Patients with treatment-resistant depression (TRD) have higher rates of relapse and pronounced decreases in daily functioning and health-related quality of life compared to patients with major depress...

Access and real-world use patterns of esketamine nasal spray among patients with treatment-resistant depression covered by private or public insurance.

To describe access and real-world use patterns of esketamine nasal spray among adults with treatment-resistant depression (TRD) with private or public insurance.... Adults with ≥1 claim for esketamine nasal spray were selected from Clarivate's Real World Data product (January 2016-March 2021). Patients with evidence of TRD initiating esketamine (index date) after... Among 535 patients with pharmacy claims for esketamine nasal spray (mean age 49.1 years; 65.4% females), 534 had the first esketamine claim being a pharmacy claim, of which 34.6% were approved, 46.3% ... Initial access to esketamine nasal spray may be hindered by prior authorization or claim filing errors. Among patients who initiated esketamine, treatment compliance generally deviates from label reco...

Assessment of health-related quality of life and health status in patients with treatment-resistant depression treated with esketamine nasal spray plus an oral antidepressant.

Patients with treatment-resistant depression (TRD) report significant deficits in physical and mental health, as well as severely impaired health-related quality of life (HRQoL) and functioning. Esket... Data from TRANSFORM-2, a phase 3, randomized, double-blind, short-term flexibly dosed study, were analyzed. Patients (aged 18-64 years) with TRD were included. The outcome assessments included the Eur... The full analysis set included 223 patients (ESK + AD: 114; AD + PBO: 109; mean [SD] age: 45.7 [11.89]). At Day 28, a lower percentage of patients reported impairment in the ESK + AD vs. AD + PBO grou... Greater improvements in HRQoL and health status were observed among patients with TRD treated with ESK + AD vs. AD + PBO.... ClinicalTrials.gov Identifier: NCT02418585....

Efficacy and Safety of Esketamine Nasal Spray in Patients with Treatment-Resistant Depression Who Completed a Second Induction Period: Analysis of the Ongoing SUSTAIN-3 Study.

Treatment-resistant depression (TRD) is a chronic illness requiring long-term treatment. Esketamine nasal spray (ESK) has been studied in several long-term trials of patients with TRD, including SUSTA... Patients aged 18-64 years who achieved stable remission or response with ESK and subsequently relapsed after randomization to continue ESK or switch to placebo nasal spray (PBO) in SUSTAIN-1 and enter... Of the 96 eligible patients who entered IND in SUSTAIN-3, 32 (33.3%) were taking ESK+AD at the time of relapse in SUSTAIN-1 and 64 (66.7%) were taking AD+PBO. Substantial improvements in depressive sy... Patients with TRD benefitted from receiving a second IND and maintenance treatment with ESK and no new safety signals were identified....

Etripamil Nasal Spray for Conversion of Repeated Spontaneous Episodes of Paroxysmal Supraventricular Tachycardia During Long-Term Follow-Up: Results From the NODE-302 Study.

Background Self-administration of investigational intranasal L-type calcium channel blocker etripamil during paroxysmal supraventricular tachycardia (PSVT) appeared safe and well-tolerated in the phas...

Determining the clinical and cost-effectiveness of nasal sprays and a physical activity and stress management intervention to reduce respiratory tract infections in primary care: A protocol for the 'Immune Defence' randomised controlled trial.

Most adults in the UK experience at least one viral respiratory tract infection (RTI) per year. Individuals with comorbidities and those with recurrent RTIs are at higher risk of infections. This can ... Immune Defence is an open, parallel group, randomised controlled trial. Up to 15000 adults from UK general practices, with a comorbidity or risk factor for infection and/or recurrent infections (3 or ... Recruitment commenced in December 2020 and the last participant is expected to complete the trial in April 2024.... Common nasal sprays and digital interventions to promote physical activity and stress management are low cost, accessible interventions applicable to primary care. If effective, they have the potentia... Prospectively registered with ISRCTN registry (17936080) on 30/10/2020.... This RCT is sponsored by University of Southampton. The sponsors had no role in the study design, decision to publish, or preparation of the manuscript....